Melinta Therapeutics Inc logo

Melinta Therapeutics Inc

€ 0.06 (0%) Apr 29
P/E:
At Loss
P/B:
0
Market Cap:
€ 825.00K ($ 841.00K)
Enterprise V:
€ 825.00K ($ 841.00K)
Volume:
-
Avg Vol (2M):
-
Also Trade In:
Volume:
-
Market Cap €:
825.00K
Market Cap $:
841.00K
PE Ratio:
At Loss
Avg Vol (2-Month):
-
Enterprise Value €:
825.00K
Enterprise Value $:
841.00K
PB Ratio:
0
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Melinta Therapeutics Inc
NAICS : 325412 SIC : 2834
44 Whippany Road, Morristown, NJ, USA, 07963
Description
Melinta Therapeutics Inc is a clinical-stage biotechnology company that develops differentiated antibiotics for acute care and community settings. The company's goal is to develop treatments for bacterial infectious diseases, particularly respiratory tract infections and staphylococcal infections. The company is particularly focused on treating community-acquired bacterial pneumonia, as well as gonorrhea and other indications.

Financial Strength

Name Current Vs Industry Vs History
Piotroski F-Score 0/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
6-1 Month Momentum % -98.11
12-1 Month Momentum % -98.79

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

Financials

FRA:9C1B's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 72.189
EPS (TTM) (€) -19.709
Beta 0
Volatility % 210.39
14-Day RSI 0
14-Day ATR (€) 0
20-Day SMA (€) 0
12-1 Month Momentum % -98.79
52-Week Range (€) 0.01 - 34
Shares Outstanding (Mil) 13.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Melinta Therapeutics Inc Filings

Document Form Filing Date
No Filing Data